Prosecution Insights
Last updated: April 19, 2026

Examiner: MEAH, MOHAMMAD Y

Tech Center 1600 • Art Units: 1652

This examiner grants 71% of resolved cases

Performance Statistics

70.8%
Allow Rate
+10.8% vs TC avg
984
Total Applications
+42.9%
Interview Lift
1144
Avg Prosecution Days
Based on 977 resolved cases, 2023–2026

Rejection Statute Breakdown

1.8%
§101 Eligibility
20.6%
§102 Novelty
35.1%
§103 Obviousness
22.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18009357 SPLIT INTEIN-BASED SELECTION FOR PEPTIDE BINDERS Non-Final OA Massachusetts Institute of Technology
17514648 SCALABLE PEPTIDE-GPCR INTERCELLULAR SIGNALING SYSTEMS Non-Final OA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18062906 MODIFIED FERRITIN AND METHOD FOR PRODUCING THE SAME Non-Final OA Ajinomoto Co., Inc.
18350985 ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS Non-Final OA Whitehead Institute for Biomedical Research
18111321 Highly Potent Acid Alpha-Glucosidase With Enhanced Carbohydrates Non-Final OA Amicus Therapeutics, Inc.
17616496 BIOACTIVE AGENTS AND METHODS RELATED THERETO Non-Final OA AROA BIOSURGERY LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month